Results 171 to 180 of about 1,428,732 (361)
This multicenter study suggests that adjuvant chemotherapy may improve survival in stage IV intrahepatic cholangiocarcinoma after resection, with S‐1 showing a potential survival advantage. ABSTRACT Background The survival benefit of adjuvant chemotherapy (AC) in intrahepatic cholangiocarcinoma (ICC) remains uncertain, particularly in advanced‐stage ...
Hisashi Kosaka +9 more
wiley +1 more source
Towards the elimination of viral hepatitis in Thailand by the year 2030
Nawarat Posuwan +6 more
openalex +1 more source
Clinical Course of Infection and Cross-Species Detection of Equine Parvovirus-Hepatitis [PDF]
Birthe Reinecke +14 more
openalex +1 more source
ROC analyses of APRI score, EOB‐MRI, and a combination of EOB‐MRI and APRI score for blue liver. ABSTRACT Aim Sinusoidal obstruction syndrome (SOS), also known as “blue liver (BL),” is a common hepatic injury following oxaliplatin‐based chemotherapy in patients with colorectal liver metastases (CRLM).
Tomonari Shimagaki +7 more
wiley +1 more source
Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice [PDF]
Yu‐Heng Lai +5 more
openalex +1 more source
Effect of alcohol on clinical complications of hepatitis virus-induced liver cirrhosis: a consecutive ten-year study [PDF]
Kodjo-Kunale Abassa +5 more
openalex +1 more source
ABSTRACT Background Nivolumab‐including chemotherapy (nivo‐CTX) for stage IV gastric cancer (GC) may increase the chance of conversion surgery but risk of immune‐related adverse events (irAEs) during perioperative period remains unclear. Methods We examined irAEs in 36 patients with marginally resectable GC who received nivo‐CTX followed by surgery ...
Masashi Nishino +11 more
wiley +1 more source
Cell Culture Isolation and Whole Genome Characterization of Hepatitis E Virus Strains from Wild Boars in Germany [PDF]
Katja Schilling‐Loeffler +6 more
openalex +1 more source

